These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24139288)

  • 1. A simple strategy to decrease fatal carotid blowout syndrome after stereotactic body reirradiaton for recurrent head and neck cancers.
    Yazici G; Sanlı TY; Cengiz M; Yuce D; Gultekin M; Hurmuz P; Yıldız F; Zorlu F; Akyol F; Gurkaynak M; Ozyigit G
    Radiat Oncol; 2013 Oct; 8():242. PubMed ID: 24139288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carotid Dosimetry and the Risk of Carotid Blowout Syndrome After Reirradiation With Head and Neck Stereotactic Body Radiation Therapy.
    Gebhardt BJ; Vargo JA; Ling D; Jones B; Mohney M; Clump DA; Ohr JP; Ferris RL; Heron DE
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):195-200. PubMed ID: 29398127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors.
    Cengiz M; Özyiğit G; Yazici G; Doğan A; Yildiz F; Zorlu F; Gürkaynak M; Gullu IH; Hosal S; Akyol F
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):104-9. PubMed ID: 20675075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carotid blowout syndrome in pharyngeal cancer patients treated by hypofractionated stereotactic re-irradiation using CyberKnife: A multi-institutional matched-cohort analysis.
    Yamazaki H; Ogita M; Himei K; Nakamura S; Kotsuma T; Yoshida K; Yoshioka Y
    Radiother Oncol; 2015 Apr; 115(1):67-71. PubMed ID: 25827266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fitting NTCP models to SBRT dose and carotid blowout syndrome data.
    Mavroidis P; Grimm J; Cengiz M; Das S; Tan X; Yazici G; Ozyigit G
    Med Phys; 2018 Oct; 45(10):4754-4762. PubMed ID: 30102783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reirradiation using robotic image-guided stereotactic radiotherapy of recurrent head and neck cancer.
    Yamazaki H; Ogita M; Himei K; Nakamura S; Suzuki G; Yoshida K; Kotsuma T; Yoshioka Y
    J Radiat Res; 2016 Jun; 57(3):288-93. PubMed ID: 26983982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region.
    Siddiqui F; Patel M; Khan M; McLean S; Dragovic J; Jin JY; Movsas B; Ryu S
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1047-53. PubMed ID: 19327895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment.
    Lee DS; Kim YS; Cheon JS; Song JH; Son SH; Jang JS; Kang YN; Kang JH; Jung SL; Yoo IeR; Jang HS
    Radiat Oncol; 2012 Jun; 7():85. PubMed ID: 22691266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of tumor volume and radiotherapy dose on outcome in previously irradiated recurrent squamous cell carcinoma of the head and neck treated with stereotactic body radiation therapy.
    Rwigema JC; Heron DE; Ferris RL; Andrade RS; Gibson MK; Yang Y; Ozhasoglu C; Argiris AE; Grandis JR; Burton SA
    Am J Clin Oncol; 2011 Aug; 34(4):372-9. PubMed ID: 20859194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
    Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
    J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body radiotherapy optimization to reduce the risk of carotid blowout syndrome using normal tissue complication probability objectives.
    Szalkowski G; Karakas Z; Cengiz M; Schreiber E; Das S; Yazici G; Ozyigit G; Mavroidis P
    J Appl Clin Med Phys; 2022 May; 23(5):e13563. PubMed ID: 35194924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic body radiation therapy for locally recurrent, previously irradiated nonsquamous cell cancers of the head and neck.
    Vargo JA; Wegner RE; Heron DE; Ferris RL; Rwigema JC; Quinn A; Gigliotti P; Ohr J; Kubicek GJ; Burton S
    Head Neck; 2012 Aug; 34(8):1153-61. PubMed ID: 22076812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage stereotactic reirradiation with or without cetuximab for locally recurrent head-and-neck cancer: a feasibility study.
    Comet B; Kramar A; Faivre-Pierret M; Dewas S; Coche-Dequeant B; Degardin M; Lefebvre JL; Lacornerie T; Lartigau EF
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):203-9. PubMed ID: 22331006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
    Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
    Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of skin invasion in recurrent head and neck cancer patients treated by hypofractionated stereotactic re-irradiation using a cyberknife.
    Yamazaki H; Ogita M; Himei K; Nakamura S; Suzuki G; Kotsuma T; Yoshida K; Yoshioka Y
    Radiat Oncol; 2015 Oct; 10():210. PubMed ID: 26471020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency, outcome and prognostic factors of carotid blowout syndrome after hypofractionated re-irradiation of head and neck cancer using CyberKnife: a multi-institutional study.
    Yamazaki H; Ogita M; Kodani N; Nakamura S; Inoue H; Himei K; Kotsuma T; Yoshida K; Yoshioka Y; Yamashita K; Udono H
    Radiother Oncol; 2013 Jun; 107(3):305-9. PubMed ID: 23751378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer.
    Rühle A; Sprave T; Kalckreuth T; Stoian R; Haehl E; Zamboglou C; Laszig R; Knopf A; Grosu AL; Nicolay NH
    Radiat Oncol; 2020 Apr; 15(1):81. PubMed ID: 32299456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT).
    Reyngold M; Wu AJ; McLane A; Zhang Z; Hsu M; Stein NF; Zhou Y; Ho AY; Rosenzweig KE; Yorke ED; Rimner A
    Radiat Oncol; 2013 Apr; 8():99. PubMed ID: 23617949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective comparison of robotic stereotactic body radiotherapy and three-dimensional conformal radiotherapy for the reirradiation of locally recurrent nasopharyngeal carcinoma.
    Ozyigit G; Cengiz M; Yazici G; Yildiz F; Gurkaynak M; Zorlu F; Yildiz D; Hosal S; Gullu I; Akyol F
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e263-8. PubMed ID: 21514737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic Body Radiotherapy for Recurrent Unresectable Head and Neck Cancers.
    Strom T; Wishka C; Caudell JJ
    Cancer Control; 2016 Jan; 23(1):6-11. PubMed ID: 27009451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.